Withdrawal of Track and Trace System for Drug Export Formulations.
The Director General of Foreign Trade has officially withdrawn Para 2.76 from the Handbook of Procedures 2023, which previously outlined the procedure for implementing the Track and Trace system for export consignments of drug formulations.
This change means that the responsibility for implementing the authentication system for drug formulations being exported will now fall under the Ministry of Health and Family Welfare. The implementation will follow the provisions set forth in the Drug Rules of 1945.
This update comes into effect immediately. For more details, exporters should refer to the Ministry of Health and Family Welfare for guidance on the new process.
DGFT
Legal
Company Secretarial
DGFT Notifications
Others
Recent Posts
- DGFT Amends Authorized Agency for Certificate of Origin (Non-Preferential)
- MIP Condition Relaxed for SEZs and EOUs
- DGFT Notifies New SION A-3686 Under Foreign Trade Policy 2023
- Govt. Eases Leather Export Rules
- DGFT Amends Import Policy for Chapter 83 under ITC (HS)
- Government Amends Import Rules for Iron & Steel Products
- Govt Extends Yellow Peas Import Policy Till March 2026
- Export Boost: Leather Product Restrictions Lifted by Government
FeATURED ARTICLES
DGFT Amends Authorized Agency for Certificate of Origin (Non-Preferential) In accordance with powers granted under Paragraph 2.04 of the Foreign…
MIP Condition Relaxed for SEZs and EOUs The Central Government has extended the Minimum Import Price (MIP) condition on certain…
DGFT Notifies New SION A-3686 Under Foreign Trade Policy 2023 In a significant development for exporters and stakeholders in the…
Govt. Eases Leather Export Rules In a recent move to boost leather exports, the Central Government has revoked export conditions…
